Cardiac left ventricular hypertrophy is a risk factor for heart failure. Morphological (structural) effects such as cardiac hypertrophy can be drug-induced therefore it is important to identify these liabilities at an early stage of drug discovery and development.
In this poster, we focus on:
- Using HCS to detect cardiac hypertrophy
- The comparison of single cell, co-culture and triculture microtissues models for predicting cardiac hypertrophy
Read our poster to learn more about our research!
